IndraLab

Statements


Mutated TP53 leads to the methylation of CDKN2A. 1 / 1
| 1

reach
"Correlation between promoter methylation of p14 ARF, TMS1 and ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma."